Deutsche Bank’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-15
Closed -$5K 4441
2020
Q2
$5K Sell
15
-6
-29% -$2.39K ﹤0.01% 4157
2020
Q1
$22K Sell
21
-57
-73% -$83.1K ﹤0.01% 3886
2019
Q4
$100K Buy
78
+64
+457% +$90.2K ﹤0.01% 3583
2019
Q3
$17K Sell
14
-76
-84% -$123K ﹤0.01% 4383
2019
Q2
$202K Buy
90
+77
+592% +$227K ﹤0.01% 3818
2019
Q1
$37K Buy
+13
New +$28.8K ﹤0.01% 4650
2018
Q4
Sell
-3
Closed -$7K 5415
2018
Q3
$7K Hold
3
﹤0.01% 5154
2018
Q2
$9K Hold
3
﹤0.01% 5172
2018
Q1
$7K Sell
3
-174
-98% -$522K ﹤0.01% 5201
2017
Q4
$724K Buy
177
+175
+8,750% +$734K ﹤0.01% 3418
2017
Q3
$9K Hold
2
﹤0.01% 4682
2017
Q2
$7K Sell
2
-2
-50% -$8.46K ﹤0.01% 4710
2017
Q1
$23K Sell
4
-28
-88% -$130K ﹤0.01% 4473
2016
Q4
$141K Sell
32
-38
-54% -$473K ﹤0.01% 3889
2016
Q3
$1.47M Buy
70
+65
+1,300% +$1.18M ﹤0.01% 2566
2016
Q2
$71K Buy
5
+4
+400% +$91.4K ﹤0.01% 4256
2016
Q1
$33K Sell
1
-4
-80% -$84.5K ﹤0.01% 4468
2015
Q4
$136K Sell
5
-31
-86% -$1.02M ﹤0.01% 3908
2015
Q3
$903K Sell
36
-1
-3% -$67.3K ﹤0.01% 3023
2015
Q2
$3.13M Buy
+37
New +$3.39M ﹤0.01% 2131
2015
Q1
Hold
0
5038
2014
Q4
Hold
0
6316
2014
Q3
Hold
0
5679
2014
Q2
Sell
-2
Closed -$47.2K 6059
2014
Q1
$41K Buy
2
+1
+100% +$28.3K ﹤0.01% 4623
2013
Q4
$16K Sell
1
-4
-80% -$110K ﹤0.01% 4798
2013
Q3
$146K Buy
5
+3
+150% +$106K ﹤0.01% 4269
2013
Q2
$73K Buy
+2
New +$75.2K ﹤0.01% 4364

Other funds holding TPST

Deutsche Bank's TPST Position: Q3 2020 in Review

Deutsche Bank sold out of Tempest Therapeutics (TPST) in Q3 2020, closing a stake of 15 shares — an estimated $5K sold.

Deutsche Bank first reported a position in TPST in Q2 2013 and held it in 24 quarters. The position peaked at $3.13M in Q2 2015. 42 funds tracked by Wall St. Rank hold TPST as of Q3 2020.

  • Deutsche Bank reported no remaining Tempest Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Deutsche Bank sold 15 Tempest Therapeutics shares in Q3 2020, an estimated $5K.
  • Deutsche Bank first reported a position in Tempest Therapeutics in Q2 2013 and held it in 24 quarters.
  • Deutsche Bank's Tempest Therapeutics position peaked at $3.13M in Q2 2015.
  • 42 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2020.

Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.